Trofinetide Completed Phase 2 Trials for Injuries, Brain Supportive Care

IndicationsStatusPurposePhase
CompletedSupportive Care2
clinicaltrials.gov IdentifierTitleDrugs
NCT00805818Study of NNZ-2566 in Patients With Traumatic Brain Injury